Skip to main content

Table 2 Estimated 10-year cardiovascular risk among Chinese antiretroviral-naïve HIV-infected patients

From: Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease

Characteristics

All n/N (%)

Male n/N (%)

Female n/N (%)

p-value

FRS

   

NA

  < 10%

921/965 (95.5%)

671/715 (93.8%)

250/250 (100%)

 

 10–20%

39/965 (4.0%)

39/715 (5.5%)

0/250 (0%)

 

  > 20%

5/965 (0.5%)

5/715 (0.7%)

0/250 (0%)

 

D:A:D Risk Score

   

NA

  < 10%

941/973 (96.7%)

692/722 (95.8%)

249/251 (99.2%)

 

 10–20%

20/973 (2.1%)

18/722 (2.5%)

2/251 (0.8%)

 

  > 20%

12 /973 (1.2%)

12/722 (1.7%)

0/251 (0%)

 

Favorable Cardiovascular Risk Profile

364/973 (37.4%)

257/722 (35.6%)

107/251 (42.6%)

0.047

  1. NA, not applicable; FRS, the Framingham Risk Score; (D:A:D) Risk Score, Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores; Favorable cardiovascular risk profile was defined on the basis of a number of modifiable risk factors as follows: total cholesterol <5.17 mmol/l, systolic blood pressure ≤ 120 mmHg, diastolic blood pressure ≤ 80 mmHg, no current smoking, no diabetes and no prior CVD